A Study of Pentasa in Patients With Ulcerative Colitis

An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase

NCT02368717 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

NCT01647516 ·Status: COMPLETED ·Phase: PHASE2

Predicting Response to Standardized Pediatric Colitis Therapy

NCT01536535 ·Status: COMPLETED ·Phase: PHASE4

A Study With Pentasa in Patients With Active Crohn's Disease

NCT00862121 ·Status: TERMINATED ·Phase: PHASE3

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease

NCT00225810 ·Status: COMPLETED ·Phase: PHASE4

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

NCT01654783 ·Status: COMPLETED

Pentoxifylline in Patients With Ulcerative Colitis

NCT07349472 ·Status: RECRUITING ·Phase: PHASE2

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis

NCT01538251 ·Status: TERMINATED ·Phase: PHASE3

Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.

NCT05575505 ·Status: RECRUITING ·Phase: PHASE2

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients

NCT03773952 ·Status: COMPLETED ·Phase: PHASE2

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

NCT00928681 ·Status: COMPLETED ·Phase: PHASE1

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

NCT05076175 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05644665 ·Status: TERMINATED ·Phase: PHASE3

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

NCT02368743 ·Status: COMPLETED

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

NCT02895100 ·Status: TERMINATED ·Phase: PHASE2

Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

NCT06176560 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03915769 ·Status: COMPLETED ·Phase: PHASE3

A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

NCT01458574 ·Status: COMPLETED ·Phase: PHASE3

Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

NCT03689673 ·Status: COMPLETED

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

User Surveillance in Ulcerative Colitis

NCT01363453 ·Status: COMPLETED

TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)

NCT01745770 ·Status: COMPLETED ·Phase: PHASE3

A Safety Study of Intravenously Administered UTTR1147A in Healthy Volunteers (HVs), Participants With Ulcerative Colitis (UC), and Participants With Crohn's Disease (CD)

NCT02749630 ·Status: COMPLETED ·Phase: PHASE1